iX Biopharma Ltd announced that on Jul, 15 2026 it allotted and issued about 11.734 million new ordinary shares following the exercise of warrants at an exercise price of 0.06 Singapore dollars apiece.

Approximately 9.566 million of the new shares were issued to Chairman and Chief Executive Officer Eddy Lee Yip Hang, while about 2.055 million shares were issued to his spouse, Tang Choy Leng Jane.

The company’s outstanding share capital has risen to roughly 1.089 billion shares from 1.077 billion shares.

In total, 53.001 million warrants—representing 92.16% of the warrants originally issued—have now been exercised. The remaining 4.508 million warrants, also exercisable at 0.06 Singapore dollars each, will expire at 5:00 p.m. on Jul, 17 2026.